Community-based support for starting buprenorphine treatment
Part of Mental health clinical trials.
This study tests whether extra support in community settings (like mobile units or outreach) helps people who are starting buprenorphine for opioid use disorder stay on treatment. It focuses on helping you continue your medication and stay healthy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 16 or older.
- You just started buprenorphine (a medication for opioid use disorder) within the last 10 days or are starting it today.
- You have not taken other opioid use disorder medications (like methadone) for more than 10 days straight in the past month.
- You are not currently in jail, prison, or a court-ordered facility.
- You can stay in the area for the next 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a peer recovery support program for people starting inpatient treatment for opioid use disorder. It aims to help you stay on medication for opioid use disorder and build a strong recovery.
This study tests a behavioral support program designed to help people newly starting buprenorphine treatment for opioid use disorder stay engaged with their care. If you've recently started buprenorphine or just been released from incarceration and are beginning treatment, this trial may help you maintain consistent medication use and reduce the risk of relapse.
This study compares two medications, methadone and buprenorphine, to see which helps people stay in treatment for opioid use disorder. You may be eligible if you are starting a new treatment episode.
This trial tests a long-acting, once-monthly injection of buprenorphine (BRIXADI) given from a mobile pharmacy clinic. It aims to see if this approach is acceptable and practical for people with opioid use disorder, making treatment more accessible.
This trial studies a program meant to improve treatment access and support recovery for people with opioid use disorder who also have mental health symptoms. It may help if you are new to the program or recently relapsed, or if mental health symptoms have worsened—even without a relapse.
This trial compares taking buprenorphine by mouth versus as an injection for opioid use disorder. It aims to see which option helps people stay on treatment and reduces opioid use over about a year.
Hear when a new Opioid Use Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.